Home / Gemcitabine / Switzerland
CH ATC L01BC05 · updated 2 Nov 2026
Gemcitabine shortage in Switzerland
Is there a Gemcitabine shortage in Switzerland?
Yes. As of 2 Nov 2026, 1 Gemcitabine product is reported short in Switzerland, the first since 15 May 2025. The company estimate for the return is 1 Jan 2030. Main reason: not stated.
Also short in Canada, Germany, France, Italy, Spain, Belgium, Czechia, Australia. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | GEMCITABIN Teva liquid 200 mg/5ml Durchstf | Teva Pharma AG | 15 May 2025 | 1 Jan 2030 | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).